Works about INVESTIGATIONAL drugs
Results: 2150
Expanding Horizons in T-Cell Lymphoma Therapy: Focus on Personalized Treatment Strategies.
- Published in:
- Oncology (08909091), 2025, v. 39, n. 2, p. 80
- By:
- Publication type:
- Article
Choosing selective factors for the cultivation of Aerococcus viridanssymbiont strains.
- Published in:
- Regulatory Mechanisms in Biosystems, 2018, v. 9, n. 3, p. 426, doi. 10.15421/021863
- By:
- Publication type:
- Article
Towards intra-articular therapies for more than just symptom management in osteoarthritis.
- Published in:
- Drugs & Therapy Perspectives, 2023, v. 39, n. 11, p. 382, doi. 10.1007/s40267-023-01029-6
- By:
- Publication type:
- Article
Computer Regression Models for P-Glycoprotein Transport of Drugs.
- Published in:
- Pharmaceutical Chemistry Journal, 2019, v. 52, n. 12, p. 975, doi. 10.1007/s11094-019-01936-x
- By:
- Publication type:
- Article
Evaluating the Efficacy and Safety of Hemofence (Thorombin Cross-Linked Sodium Hyaluronate Gel Matrix) in Hemostasis for Intractable Exudative Bleeding in Spinal Surgery: A Multicenter, Randomized, Phase III Clinical Trial.
- Published in:
- Neurospine, 2024, v. 21, n. 3, p. 1004, doi. 10.14245/ns.2448024.012
- By:
- Publication type:
- Article
Use of Placebo in Pediatric Inflammatory Bowel Diseases: A Position Paper From ESPGHAN, ECCO, PIBDnet, and the Canadian Children IBD Network.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Update: Temporary Total Depletion of U.S. Licensed Yellow Fever Vaccine for Civilian Travelers Addressed by Investigational New Drug Use of Imported Stamaril Vaccine.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Addressing a Yellow Fever Vaccine Shortage - United States, 2016-2017.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Investigational Drug Available Directly from CDC for the Treatment of Infections with Free-Living Amebae.
- Published in:
- MMWR: Morbidity & Mortality Weekly Report, 2013, v. 62, n. 33, p. 666
- By:
- Publication type:
- Article
Preclinical and Clinical Investigations of Potential Drugs and Vaccines for COVID-19 Therapy: A Comprehensive Review With Recent Update.
- Published in:
- Clinical Pathology, 2024, p. 1, doi. 10.1177/2632010X241263054
- By:
- Publication type:
- Article
Glioblastoma Break-in; Try Something New.
- Published in:
- International Journal of Cancer Management, 2021, v. 14, n. 1, p. 1, doi. 10.5812/ijcm.109054
- By:
- Publication type:
- Article
Bioanalytical strategies in drug discovery and development.
- Published in:
- Drug Metabolism Reviews, 2021, v. 53, n. 3, p. 434, doi. 10.1080/03602532.2021.1959606
- By:
- Publication type:
- Article
Good drug, bad luck: business, regulatory issues can create obstacles for drug development.
- Published in:
- 2004
- By:
- Publication type:
- journal article
Re: Role of body surface area in dosing of investigational anticancer agents in adults, 1991-2001.
- Published in:
- 2003
- By:
- Publication type:
- commentary
Inhibition of the β-carbonic anhydrase from the protozoan pathogen Trichomonas vaginalis with sulphonamides.
- Published in:
- Journal of Enzyme Inhibition & Medicinal Chemistry, 2021, v. 36, n. 1, p. 330, doi. 10.1080/14756366.2020.1863958
- By:
- Publication type:
- Article
Tirzepatide for management of type 2 diabetes.
- Published in:
- Diabetes & Primary Care, 2024, v. 26, n. 2, p. 43
- By:
- Publication type:
- Article
Newer lipid-lowering therapies in type 2 diabetes.
- Published in:
- Diabetes & Primary Care, 2023, v. 25, n. 5, p. 161
- By:
- Publication type:
- Article
Frequently asked questions: SGLT2 inhibitors - a novel approach to managing hyperglycaemia.
- Published in:
- Diabetes & Primary Care, 2013, v. 15, n. 4, p. 172
- By:
- Publication type:
- Article
Two views of cancer medicines: Imagery versus evidence.
- Published in:
- Health Marketing Quarterly, 2023, v. 40, n. 2, p. 141, doi. 10.1080/07359683.2021.1997512
- By:
- Publication type:
- Article
Facing the threat of antimicrobial resistance.
- Published in:
- British Journal of Healthcare Management, 2016, v. 22, n. 2, p. 95, doi. 10.12968/bjhc.2016.22.2.95
- By:
- Publication type:
- Article
Expanding Roles for Pathologists as Members of the Multidisciplinary Cancer Care Team.
- Published in:
- Personalized Medicine in Oncology, 2016, v. 5, n. 10, p. 411
- By:
- Publication type:
- Article
Published Studies Underreport Toxicities Associated with Targeted Therapy and Immunotherapy.
- Published in:
- Personalized Medicine in Oncology, 2016, v. 5, n. 9, p. 379
- Publication type:
- Article
A New Approach to Cell Culturing.
- Published in:
- Personalized Medicine in Oncology, 2016, v. 5, n. 8, p. 316
- Publication type:
- Article
Addition of Bcl-2 Inhibitor to MM Regimen Produces Promising Responses in Relapsed/Refractory MM.
- Published in:
- Personalized Medicine in Oncology, 2016, v. 5, n. 6, p. 258
- Publication type:
- Article
"Smart Bomb" Drug: Rova-T Promising in SCLC.
- Published in:
- Personalized Medicine in Oncology, 2016, v. 5, n. 6, p. 248
- Publication type:
- Article
Select Ongoing Trials Currently Enrolling Patients with Colorectal Cancer.
- Published in:
- Personalized Medicine in Oncology, 2016, v. 5, n. 5, p. 206
- Publication type:
- Article
The Coming Government Takeover of Drug Pricing.
- Published in:
- Personalized Medicine in Oncology, 2016, v. 5, n. 1, p. 47
- By:
- Publication type:
- Article
Venetoclax: Strong Showing in CLL.
- Published in:
- Personalized Medicine in Oncology, 2016, v. 5, n. 1, p. 31
- By:
- Publication type:
- Article
Potential New Approach to Treatment of Melanoma.
- Published in:
- Personalized Medicine in Oncology, 2014, v. 3, n. 4, p. 235
- Publication type:
- Article
Anti-PD-1/PD-L1 Therapy: New Immunotherapy Options for Patients With a Variety of Cancers.
- Published in:
- Personalized Medicine in Oncology, 2014, v. 3, n. 3, p. 144
- By:
- Publication type:
- Article
A Breakthrough Treatment for ALL and CLL: The New Biologic Agent, CTL019.
- Published in:
- Personalized Medicine in Oncology, 2014, v. 3, n. 3, p. 138
- Publication type:
- Article
ALL: Genetics Providing New Insights Into Signaling Pathways and Treatment Targets.
- Published in:
- Personalized Medicine in Oncology, 2014, v. 3, n. 1, p. 56
- Publication type:
- Article
I-SPY 2: First Results Based on Biomarkers/Genetic Signatures in Breast Cancer.
- Published in:
- Personalized Medicine in Oncology, 2014, v. 3, n. 1, p. 47
- Publication type:
- Article
Breast Cancer Agents in the Pipeline.
- Published in:
- Personalized Medicine in Oncology, 2014, v. 3, n. 1, p. 46
- Publication type:
- Article
Clinical Approaches to Targeted Technologies: Highlights from the Second Annual Conference of the Global Biomarkers Consortium.
- Published in:
- Personalized Medicine in Oncology, 2014, v. 3, n. 1, p. 32
- By:
- Publication type:
- Article
Pharmacologic Perspectives on Novel Therapies in Multiple Myeloma.
- Published in:
- Personalized Medicine in Oncology, 2014, v. 3, n. 1, p. 29
- By:
- Publication type:
- Article
Partners HealthCare Center for Personalized Genetic Medicine: Utilizing Genetics and Genomics to Improve Care of Patients.
- Published in:
- Personalized Medicine in Oncology, 2014, v. 3, n. 1, p. 18
- Publication type:
- Article
PROGRESS REPORT: Implementation of ASCO's Blueprint for Transforming Clinical and Translational Cancer Research.
- Published in:
- Personalized Medicine in Oncology, 2014, v. 3, n. 1, p. 14
- Publication type:
- Article
Using the Untested Ebola Drug in Ebola Affected Patients: An Ethical Dilemma.
- Published in:
- 2015
- By:
- Publication type:
- Letter to the Editor
Using the Untested Ebola Drug in Ebola Affected Patients: An Ethical Dilemma.
- Published in:
- 2014
- By:
- Publication type:
- Letter to the Editor
Efforts Made to Eliminate Drug-Resistant Malaria and Its Challenges.
- Published in:
- BioMed Research International, 2021, p. 1, doi. 10.1155/2021/5539544
- By:
- Publication type:
- Article
Colesevelam for Type 2 diabetes mellitus: an abridged Cochrane review.
- Published in:
- Diabetic Medicine, 2014, v. 31, n. 7, p. 880, doi. 10.1111/dme.12424
- By:
- Publication type:
- Article
Enhancing Clinical Trials Through Synergistic Gamma Power Analysis.
- Published in:
- Frontiers in Psychiatry, 2020, v. 11, p. 1, doi. 10.3389/fpsyt.2020.00537
- By:
- Publication type:
- Article
Leveraging National Cancer Institute Programmatic Collaboration for Single Radiopharmaceutical Drug Master Files.
- Published in:
- Frontiers in Oncology, 2019, p. N.PAG, doi. 10.3389/fonc.2019.00573
- By:
- Publication type:
- Article
Constructing and Characterizing Bacteriophage Libraries for Phage Therapy of Human Infections.
- Published in:
- Frontiers in Microbiology, 2019, v. 10, p. 1, doi. 10.3389/fmicb.2019.02537
- By:
- Publication type:
- Article
Post-trial access to investigational drugs in India: addressing challenges in the regulatory framework.
- Published in:
- Medical Law Review, 2024, v. 32, n. 1, p. 20, doi. 10.1093/medlaw/fwad028
- By:
- Publication type:
- Article
A descriptive study of new drug approvals during 2017-2021 and disease morbidity and mortality patterns in India.
- Published in:
- Perspectives in Clinical Research, 2024, v. 15, n. 2, p. 66, doi. 10.4103/picr.picr_109_23
- By:
- Publication type:
- Article
A two-year evaluation of the minutes of Investigational New Drug committee meetings.
- Published in:
- Perspectives in Clinical Research, 2021, v. 12, n. 4, p. 199, doi. 10.4103/picr.PICR_83_19
- By:
- Publication type:
- Article
Role of investigational new drug committees in propelling the drug development ecosystem in India.
- Published in:
- Perspectives in Clinical Research, 2021, v. 12, n. 4, p. 177, doi. 10.4103/picr.picr_190_21
- By:
- Publication type:
- Article
Pharmacovigilance and assessment of drug safety reports during COVID 19.
- Published in:
- Perspectives in Clinical Research, 2020, v. 11, n. 3, p. 128, doi. 10.4103/picr.PICR_171_20
- By:
- Publication type:
- Article